Activity Dates: 11/01/2017 - 12/31/2019
The Psychiatric Pharmacotherapy Review Book is designed for three primary audiences:
NOTE: The Psychiatric Pharmacotherapy Review Book is a two-year product released at the start of even years (2018, 2020, 2022...).
The Psychiatric Pharmacotherapy Review Book is designed for use by individuals preparing to sit for the Board Certified Psychiatric Pharmacist (BCPP) examination. CPNP surveys show that at least 90% of successful BCPP candidates purchase the Review Book as their primary study tool. One hundred percent of survey respondents indicate that the Review Book was their primary study resource and a key tool to their certification success.
The Book Contains:
AAPP has invested in supporting the most popular web browsers and leveraging software that our members use daily. Beyond PDF downloads, the rest of the system is built on HTML5, a technology that most up-to-date browsers will support. To access AAPP course materials online, you will need:
AAPP web sites no longer fully support Microsoft Internet Explorer or Windows 8.1 and older. We cannot guarantee that the site will function perfectly on every device and configuration, but using the latest version of the software above will greatly improve your experience.
Jolene Bostwick, PharmD, BCPS, BCPP
Associate Chair & Clinical Associate Professor, Department of Clinical Pharmacy No Relevant Financial Relationships to Disclose My presentation will include discussion of off-label, experimental, and /or investigational use of drugs or devices: psychotropics used to treat psychiatric comorbidities. May be others; however, information will be based on published literature and will be clearly stated the medications are off-label |
Steven Burghart, RPh, DPh, MBA, BCPP
Clinical Pharmacist Psychiatry No Relevant Financial Relationships to Disclose |
Joshua Caballero, PharmD, BCPP, FCCP
Professor No Relevant Financial Relationships to Disclose Presentation will include discussion of off-label, experimental, and/or investigational use of drugs or devices: psychotropics used to treat psychiatric comorbidities. May be others; however, information will be based on published literature and will be clearly stated the medications are off-label |
Ryan Carnahan, PharmD, MS, BCPP
Associate Professor No Relevant Financial Relationships to Disclose |
Norman Carroll, BSPharm, MS, PhD
Professor No Relevant Financial Relationships to Disclose |
Megan Ehret, PharmD, MS, BCPP
Associate Professor
University of Maryland
Baltimore, MD External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Barrons PCAT Review Book Evaluator, PSAP Book Chapter Author |
Lisa W. Goldstone, PharmD, MS, BCPS, BCPP
Associate Professor of Clinical Pharmacy No Relevant Financial Relationships to Disclose |
Cynthia A. Gutierrez, PharmD, MS, BCPP
Clinical Pharmacy Program Manager, Mental Health No Relevant Financial Relationships to Disclose Presentation will include discussion of off-label, experimental, and/or investigational use of drugs or devices: Lithium, triiodothyronine, buspirone, risperidone as augmentation strategies for depression |
Calleen Lavinghousez, PharmD, BCPS, BCPP
VISN 7 Academic Detailing Pharmacist, Mental Health Clinical Pharmacy Specialist No Relevant Financial Relationships to Disclose Presentation will include discussion of off-label, experimental, and/or investigational use of drugs or devices: gabapentin |
Megan Maroney, PharmD, BCPP
Clinical Associate Professor No Relevant Financial Relationships to Disclose External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Janssen Connect (division of Janssen Pharmaceuticals); Speakers Bureau: Otsuka-Lundbeck EXCEL Speaker's Bureau |
Sandra Mullen, PharmD, BCPP
Clinical Pharmacy Specialist-Psychiatry Other Financial or Material Support: CVS/pharmacy employee stock |
Carol Ott, PharmD, BCPP
Clinical Professor of Pharmacy Practice Non-Financial Interests: Indiana Medicaid Drug Utilization Review (DUR) Board, Indiana Medicaid Mental Health Quality Advisory Committee (MHQAC), Primary Care Psychiatry Foundation Board of Directors, NAMI West Central Board of Directors |
Chris Paxos, PharmD, BCPP, BCPS, BCGP
Pharmacotherapy Specialist No Relevant Financial Relationships to Disclose |
Kimberly Tallian, PharmD, BCPP, FASHP, FCCP, FCSHP
Psychiatry Pharmacy Specialist No Relevant Financial Relationships to Disclose |
Traci Turner, PharmD, BCPP
Clinical Pharmacy Specialist No Relevant Financial Relationships to Disclose |
Topic |
---|
Anxiety and Anxiety-Related Disorders
Author: Jolene Bostwick, PharmD, BCPS, BCPP
|
Biostatistics and Research Design in Psychiatry
Author: Ryan M. Carnahan, PharmD, MS, BCPP
|
Bipolar Disorder
Author: Carol Ott, PharmD, BCPP
|
Depression
Author: Cynthia A. Gutierrez, PharmD, MS, BCPP
|
Economic and Outcome Studies in Psychiatry
Author: Norman Carroll, BSPharm, MS, PhD
|
Neurocognitive Disorders
Author: Joshua Caballero, PharmD, BCPP
|
Neurodevelopmental, Disruptive, Impulse-Control and Conduct Disorders
Author: Sandra Mullen, PharmD, BCPP
|
Neurologic Disorders
Author: Kimberly Tallian, PharmD, APH, BCPP, FASHP, FCCP, FCSHP
|
Personality Disorders and Eating Disorders
Author: Traci Turner, PharmD, BCPP
|
Regulatory Issues in Pharmacy Practice
Author: Steven Burghart, DPh, MBA, BCPP
|
Schizophrenia Spectrum and Other Psychotic Disorders
Author: Lisa W. Goldstone, MS, LPC, PharmD, BCPS, BCPP
|
Sleep-Wake Disorders
Author: Megan Maroney, PharmD, BCPP
|
Substance-Related Disorders
Author: Calleen Lavinghousez, PharmD, BCPS, BCPP
|
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
2018-2019 Editorial Board
Benjamin Chavez, PharmD, BCPP, BCACP Associate Professor University of Colorado Skaggs School of Pharmacy Aurora, CO External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: ACSAP Book Chapter Author Non-Financial Interests: Board of Directors of CPNP |
Megan J. Ehret, PharmD, MS, BCPP |
Clayton D. English, PharmD, BCPP, BCPS |
Rex S. Lott, PharmD, BCPP Professor Emeritus of Pharmacy Practice Idaho State University - College of Pharmacy Meridian, ID No Relevant Financial Relationships to Disclose |
Carol A. Ott, PharmD, BCPP |
Chris Paxos, PharmD, BCPP, BCPS, BCGP Pharmacotherapy Specialist Cleveland Clinic Akron General Akron, OH No Relevant Financial Relationships to Disclose |
Stephanie V. Phan, PharmD, BCPP |
Todd J. Woodard, PharmD, BCPP, BCPS, BCGP, CPE Manager, Clinical Pharmacy Services Peach State Health Plan Atlanta, GA Adjunct Clinical Assistant Professor of Pharmacy Practice Philadelphia College of Osteopathic Medicine School of Pharmacy Suwanee, GA No Relevant Financial Relationships to Disclose |
Jennifer L. Zacher, PharmD, BCPP Assistant Chief Consultant VA Pharmacy Benefits Management Service Hines, IL No Relevant Financial Relationships to Disclose |
2018-2019 Peer Reviewers
Katie Adams, PharmD, BCPP, BCPS |
Cassandra Clement, PharmD, BCPS, BCPP Mental Health Clinical Pharmacy Specialist Orlando VA Medical Center Orlando, FL No Relevant Financial Relationships to Disclose |
Nicole Cupples, PharmD, BCPP, BCPS Clinical Pharmacist South Texas Veterans Healthcare System San Antonio, TX No Relevant Financial Relationships to Disclose |
Kathryn DeMent, BCPS, BCPP Clinical Pharmacist Eastern Kansas VAMC Topeka, KS No Relevant Financial Relationships to Disclose |
Lauren Diefenderfer, PharmD, BCPP Clinical Pharmacist Center for Behavioral Medicine Kansas City, MO No Relevant Financial Relationships to Disclose |
Amie Jo Digatono, PharmD, BCPP Pharmacist Mercy Hospital - Unity Campus Fridley, MN No Relevant Financial Relationships to Disclose |
Courtney Eatmon, PharmD, BCPP Clinical Pharmacist Veterans Affairs Medical Center Lexington, KY External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: BPS specialty council as a non-specialist member of pharmacotherapy board |
Jessica Goren, PharmD, BCPP |
Tonya Gross, PharmD, BCPP Clinical Pharmacist Avera Behavioral Health Center Sioux Falls , SD No Relevant Financial Relationships to Disclose |
Beth Hall, PharmD, BCPP Director of Pharmacy Fulton State Hospital Fulton, MO No Relevant Financial Relationships to Disclose |
Jessica Ho, PharmD, BCPP, BCPS Clinical Pharmacy Specialist, Psychiatry Kaiser Permanente of the Mid-Atlantic States Burke, VA No Relevant Financial Relationships to Disclose |
Cherry Jackson, PharmD, BCPP, FASHP Professor of Pharmacy, Auburn University; Professor of Medicine, University of Alabama, Birmingham Auburn University Harrison School of Pharmacy, University of Alabama, Birmingham, School of Medicine Birmingham, AL Non-Financial Interests: CPNP, ASHP, AlSHP |
Ismar Karadzic, PharmD, BCPP Regional Director of Pharmacy Eastern Missouri Psychiatric Hospital System Regional Director of Pharmacy St. Louis, MO No Relevant Financial Relationships to Disclose |
Katherine Koller, PharmD, BCPP Psychiatric Clinical Pharmacy Specialist Battle Creek VA Medical Center Battle Creek, MI No Relevant Financial Relationships to Disclose |
Marketa Marvanova, PharmD, BCGP, BCPP, PhD |
Lindsey N. Miller, PharmD, BCPP |
Jason Noel, PharmD, BCPP Faculty University of Maryland Baltimore, MD No Relevant Financial Relationships to Disclose |
William Olsufka, PharmD, BCPP Assistant Professor Touro College of Pharmacy New York, NY No Relevant Financial Relationships to Disclose |
Mamta Parikh, PharmD, BCPS, BCPP Assistant Professor, Clinical and Administrative Sciences School of Pharmacy Notre Dame of Maryland University Baltimore , MD Employment: Notre Dame of Maryland University School of Pharmacy |
Alyssa Peckham, PharmD, BCPP Assistant Professor of Pharmacy Practice Midwestern University Glendale, AZ No Relevant Financial Relationships to Disclose |
Talia Puzantian, PharmD, BCPP Associate Professor Keck Graduate Institute Claremont, CA No Relevant Financial Relationships to Disclose |
Shannon Saldana, PharmD, MS, BCPP Pharmacy Clinical Specialist, Psychiatry Primary Children's Hospital Sandy, UT No Relevant Financial Relationships to Disclose |
Thomas Smith, PharmD, BCPP Assistant Professor of Pharmacy Practice Manchester College of Pharmacy Fort Wayne, IN No Relevant Financial Relationships to Disclose |
Gita Soltani, PharmD, BCCP, BCPS Clinical Pharmacist Florida State Hospital Chattahoochee, FL No Relevant Financial Relationships to Disclose |
Katy Tomisser, PharmD, BCPP Director of Pharmacy Western State Hospital Pharmacy Lakewood, WA No Relevant Financial Relationships to Disclose |
Gabriela Williams, PharmD, BCPS, BCPP Clinical Pharmacy Specialist, Psychiatry Eskenazi Health Indianapolis, IN No Relevant Financial Relationships to Disclose |
All relevant relationships have been mitigated.
This activity may include discussions of products or devices that are not currently approved for use by the Food and Drug Administration (FDA), or are currently investigational.
In accordance with the Food and Drug Administration (FDA), it is disclosed that there is the potential for discussions concerning off-label uses of a commercial product/devices during this educational activity.
Any person who may contribute to the content of this continuing education activity must disclose significant relationships (and any known relationships of their spouse/partner) with commercial companies whose products or services are discussed in this activity. Significant relationships include receiving from a commercial company research grants, consultant fees, travel, other benefits, or having a self-managed equity interest in a company.
Disclosure of a relationship is not intended to suggest or condone any bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.